Post Parker Institute Researchers Highlighted at CRI-ENCI-AACR Sixth International Cancer Immunotherapy Conference #CICON22
Post LumaBridge and the Parker Institute for Cancer Immunotherapy Form Strategic Alliance to Speed Access to Clinical Trial Services for Partners